Special Issue "Orally Disintegrating Dosage Forms Based on Cyclodextrins and Hydrophilic Polymers"
Deadline for manuscript submissions: 20 December 2023 | Viewed by 2204
Interests: cyclodextrins; drug delivery systems; drug-in-cyclodextrins-in-colloidal systems; microparticulate systems
Special Issues, Collections and Topics in MDPI journals
Special Issue in Applied Sciences: Cyclodextrin-Based Materials and Applications
Special Issue in Pharmaceutics: Pharmaceutics and Drug Delivery in Italy, 2nd Edition
Orally disintegrating delivery systems (ODDSs) are pharmaceutical forms designed to rapidly disintegrate or dissolve in the oral cavity without using water. Tablets, capsules, films, patches, strips, wafers, granules, micro and nano systems or others aimed both for a local and systemic action can improve the onset of action and the compliance in children or patients with swallowing challenges. On the other hand, a low drug solubility can be a problem for an OD dosage form, not only for palatability reduction but also for drug bioavailability. Hydrophilic polymers can be employed as pharmaceutical excipients due to their ability to improve drug bioavailability, stability and acceptability, moreover, hydrophilic polymers properties can be exploited to improve ODD disintegration. This Special Issue serves to highlight the application of hydrophilic polymers in ODDs. We invite articles on all pharmaceutical dosage forms of hydrophilic polymers-based ODDs for this Special Issue.
Dr. Francesca Maestrelli
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- orally disintegrating
- hydrophilic polymers
- drug solubility
- drug dissolution